Spojené státy - angličtina - NLM (National Library of Medicine)

xgen pharmaceuticals djb, inc. - streptomycin sulfate (unii: cw25ikj202) (streptomycin - unii:y45qso73ob) - streptomycin 1 g - streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below: - mycobacterium tuberculosis: the advisory council for the elimination of tuberculosis, the american thoracic society, and the center for disease control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (inh), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of inh or rifampin resistance is very low. the need for a fourth drug should be reassessed when the results of susceptibility testing are known. in the past when the national rate of primary drug resistance to isoniazid was known to be less than 4% and was either stable or declining, therapy with two and three drug regimens was considered adequate. if community rates of inh resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be co

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

al-madina pharmaceuticals ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

bengal remedies ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 313 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

biopharma ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 313 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

chemist laboratories ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

eon pharmaceuticals ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd., tongi,gazipur - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

ethical drug ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

fnf pharmaceuticals ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm

Bangladéš - angličtina - DGDA (Directorate General of Drug Administration)

gentry pharmaceuticals ltd. - streptomycin + sulfadiazine + sulfadimidine + sulfapyridine - bolus - 250 mg + 1.583 gm + 1.583 gm + 1.583 gm